Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

Depression and anxiety are linked to a higher risk of heart attack, heart disease and stroke, and researchers now think they ...

AI can detect biological signs of Alzheimer's disease years before symptoms are noted by the patient or their loved ones using only a 3-minute digital assessment delivered in a physician's office. New ...

A new study has found that changes in the brain linked to Alzheimer’s disease are more common than we thought in very old ...

Which is why, in part, the promise — and boom — of blood biomarkers testing has moved quickly in the past three to five years, researchers say. The FDA recently cleared two blood tests that detect ...

New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease ...

A pioneering study indicates that Alzheimer’s disease is considerably more widespread among individuals over 85 than previously believed. The research also found that over one in ten people aged 70 ...

Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...

The journey through Alzheimer’s disease is a complex and challenging one, not just for patients, but for their families and ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

New research has provided the first ever population-based data on the frequency of Alzheimer's disease neuropathological changes (ADNC) -- a key causal factor behind the development of dementia -- and ...

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...